|
Volumn 92, Issue 3, 2001, Pages 519-523
|
Phase II evaluation of paclitaxel, α-interferon, and cis-retinoic acid in advanced renal cell carcinoma
|
Author keywords
Biochemotherapy; Clinical trials; Kidney carcinoma; Phase II
|
Indexed keywords
ALPHA INTERFERON;
ISOTRETINOIN;
PACLITAXEL;
ADULT;
ADVANCED CANCER;
AGED;
ANEMIA;
ARTICLE;
ASTHENIA;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
FEMALE;
HUMAN;
HYPERSENSITIVITY;
INOPERABLE CANCER;
KIDNEY CARCINOMA;
MAJOR CLINICAL STUDY;
MALE;
NEUTROPENIA;
PHASE 2 CLINICAL TRIAL;
PRIORITY JOURNAL;
RASH;
|
EID: 0035425352
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/1097-0142(20010801)92:3<519::aid-cncr1350>3.0.co;2-%23 Document Type: Article |
Times cited : (22)
|
References (25)
|